NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫療保健研究受託機關(CRO)的全球市場

Healthcare Contract Research Organization (CRO)

出版商 Global Industry Analysts, Inc. 商品編碼 994584
出版日期 內容資訊 英文 176 Pages
商品交期: 最快1-2個工作天內
價格
醫療保健研究受託機關(CRO)的全球市場 Healthcare Contract Research Organization (CRO)
出版日期: 2021年04月01日內容資訊: 英文 176 Pages
簡介

全球醫療保健研究受託機關(CRO)的市場規模,預計在分析期間(2020年∼2027年)將以5.2%的年複合成長率增長,從2020年的384億美元,到2027年達到547億美元。

本報告所分析的市場區隔之一的臨床部門,在分析期間中預計將以5.3%的年複合成長率增長,達到446億美元。

本報告提供全球醫療保健研究受託機關(CRO)市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Axcent Advanced Analytics (A3)
  • BIO Agile Therapeutics
  • Charles River Laboratories
  • Covance, Inc.
  • Firma Clinical Research
  • GVK Biosciences Private Limited
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • Medpace Holdings
  • Paraxel International
  • Pharmaceutical Product Development, LLC (PPD)
  • Pharmaron
  • PPD
  • PRA Health Sciences
  • PSI CRO AG
  • SGS
  • Syneos Health

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • 競爭的市場佔有率:各市場區隔
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

IV. 競爭

  • 企業簡介:35公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP21923

Abstract:

Global Healthcare Contract Research Organization (CRO) Market to Reach $54.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Healthcare Contract Research Organization (CRO) estimated at US$38.4 Billion in the year 2020, is projected to reach a revised size of US$54.7 Billion by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. Clinical, one of the segments analyzed in the report, is projected to record a 5.3% CAGR and reach US$44.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pre-Clinical segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $11.3 Billion, While China is Forecast to Grow at 4.8% CAGR

The Healthcare Contract Research Organization (CRO) market in the U.S. is estimated at US$11.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.6 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Drug Discovery Segment to Record 4.3% CAGR

In the global Drug Discovery segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.3 Billion in the year 2020 will reach a projected size of US$3.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.3 Billion by the year 2027.

Select Competitors (Total 35 Featured) -

  • Axcent Advanced Analytics (A3)
  • BIO Agile Therapeutics
  • Charles River Laboratories
  • Covance, Inc.
  • Firma Clinical Research
  • GVK Biosciences Private Limited
  • ICON, plc.
  • IQVIA
  • Medidata Solutions, Inc.
  • Medpace Holdings
  • Paraxel International
  • Pharmaceutical Product Development, LLC (PPD)
  • Pharmaron
  • PPD
  • PRA Health Sciences
  • PSI CRO AG
  • SGS
  • Syneos Health

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Clinical Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Quality Management / Assurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Project Management / Clinical Supply Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Regulatory / Medical Affairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 28: USA Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 31: USA Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 34: Canada Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 37: Canada Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 40: Japan Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 43: Japan Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 46: China Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 49: China Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 52: Europe Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 61: France Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 64: France Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 67: Germany Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 70: Germany Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 73: Italy Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 76: Italy Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 79: UK Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 82: UK Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 85: Rest of Europe Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 88: Rest of Europe Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 90: Rest of Europe 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 91: Asia-Pacific Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 94: Asia-Pacific Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 96: Asia-Pacific 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 97: Rest of World Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2012, 2020 & 2027
    • TABLE 100: Rest of World Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of World Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of World 15-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 35